ZoomRx vs MCT2D
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ZoomRx
This platform connects doctors, patients, and pharmaceutical companies for real-time data collection through surveys. It aims to improve healthcare system efficiency by accelerating information flow and enhancing user experiences. Surveys are conducted adhering to CASRO guidelines.
- Real-time survey panels
- Connects doctors, patients, pharma
- Information flow acceleration
- CASRO compliant surveys
- Data collection from stakeholders
Read full descriptionHide full description
ZoomRx is a survey platform that facilitates communication between doctors, patients, and pharmaceutical companies. The application enables patient/research organizations, pharmaceutical/biotech companies, and other survey sponsoring entities to collect information from "connected real-time panels" of patients, doctors, insurance providers, pharmacists and other stakeholders in the healthcare system. The surveys taken on ZoomRx will enhance the experience and lives of all parties involved in the health-care system by quickening the rate of information flow. The surveys on ZoomRx are designed as per guidelines issued by the Council of American Survey Research Organizations (CASRO). We adhere to the code of standards and ethics laid out by CASRO. If you have any questions on ZoomRx, please e-mail: info@zoomrx.com
MCT2D
This app provides resources and tools for managing type 2 diabetes. It includes a coverage checker for medications and devices, a library of curated resources for patients and providers, and news updates. Users can also register for learning community events.
- Coverage checker for medications and devices
- Curated resource library
- News articles
- Learning community event registration
- Filterable resources
- Bookmarking favorite tools
Read full descriptionHide full description
The Michigan Collaborative for Type 2 Diabetes (MCT2D) was established in 2021 to accelerate a new way forward, through collaboration, innovation, and investment in quality, evidence based care for type 2 diabetes. MCT2D strives to remove barriers to guideline concordant care, support participating practices, and keep patients central to quality improvement work. The MCT2D app provides much of the same information for our participating members and for members of the public as our website, mct2d.org, in a condensed format. The app provides a registration link to our next upcoming learning community event, news articles published by the team, a condensed version of our Coverage Checker tool, and our growing collection of resources for providers and patients based on our CGM, medication, and low carb diet initiatives. More details on each part of our app are below. Coverage Checker MCT2D collects and maintains a curated set of coverage data for CGM, GLP-1 RA & GIP, and SGLT2i medications for specific popular medical plans in the state of Michigan. Users can select a product type, plan type, and plans from the dropdown lists. After making their selections, the user is presented with a list of preferred and non-preferred options covered by their selected plan. If available, there are also links to formularies or other relevant documents. Tools & Resources MCT2D's curated selection of resources is adapted for easy access on the mobile screen. As with the resource library at mct2d.org/resource-library, the resources are filterable by various categories. For specific resources, mobile-specific versions of the tools have been designed to be more readable on a phone screen. Users can also bookmark their favorite tools for quick access later. Optionally, users can share links to these resources via email or text by providing a phone number or email. We do not share this data with anyone. MCT2D News All news articles published on mct2d.org are also available in the app. Filters are also provided to help users find specific categories of news.
Screenshots
Verdict
The clearest difference is review sentiment: MCT2D at 100% against ZoomRx's 61%. MCT2D also leads on rating (5.0 vs 4.6). ZoomRx's advantage is ratings volume (407 vs 2) and iOS requirement (13.0 vs 15.1). On price, update cadence, ads and in-app purchases there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
MCT2D holds the better App Store score, 5.0 against 4.6. That said, the two scores are not equally well evidenced: ZoomRx has 407 ratings behind it against 2, so its average is the more settled of the two. Written reviews point the same way: 61% of ZoomRx's written reviews are positive against 100% of MCT2D's.
ZoomRx ships an update every 2 months, MCT2D every 5 weeks. Both last shipped on September 26, 2026.
| Parameter | ZoomRx | MCT2D |
|---|---|---|
| Price | Free | Free |
| Rating | 4.6 (407 ratings) | 5.0 (2 ratings) — better |
| Positive reviews | 61.0% of reviews | 100.0% of reviews — better |
| Number of ratings | 407 — better | 2 |
| Update frequency | Every 2 months | Every 5 weeks — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 13.0 — better | 15.1 |
| Further details — not scored | ||
| Size | 37 MB | 33 MB |
| Age rating | 4+ | 17+ |
| Developer | ZoomRx Inc. | The University of Michigan |
Customer experience
ZoomRx
MCT2D
Bugs and requests
ZoomRx
Reported bugs
8 issues- App no longer loads
- Surveys are buggy and freeze
- Cannot access payment
- Surveys stop headphone playback
- Print too small and cannot zoom
Show 3 moreShow fewer
- Screening questions repeated
- App does not load at all
- Can't sign up
Requested features
13 requests- Ability to zoom on survey print
- Option to combine medication usage
- Better tracking of medication combinations
- More surveys for pediatricians/general providers
- More surveys for specific conditions
Show 8 moreShow fewer
- Minimum compensation for disqualified data
- Better spectrum of diseases for surveys
- Faster customer service response
- Improved app loading times
- More opportunities for experienced practitioners
- Increased survey availability
- Higher compensation for surveys
- Improved survey stability
MCT2D
Not enough reviews yet to summarise bugs or requests.
In-app purchases
ZoomRx
No in-app purchases
MCT2D
No in-app purchases









